Alex will drive global commercial strategy and help scale Qinecsa’s next-generation pharmacovigilance technology across the life sciences ecosystem London, UK – January 12th, 2025 – Qinecsa, the
Beena Wood will build on the pure-bred pharmacovigilance specialist’s deep domain expertise and technology-powered solution portfolio to help reframe the contribution of drug safety London,
As the year comes to a close, Qinecsa reflects on a successful 2025 filled with global engagement and innovation in pharmacovigilance. Our team participated in key industry events across North
Qinecsa COO, John Cogan, has been featured in European Pharmaceutical Manufacturer‘s latest article, where he discusses AI’s relevance in powering the pharmacovigilance engine. As pharmacovigilance
Molecule to Market is a podcast focused on the pharmaceutical and biotech industries, particularly the outsourcing and supply chain side of drug development. Hosted by Raman
Whitepaper Bridging the Gap to ROI: The Power of Technology Backed by Expertise Writers: John Fitzpatrick, Chief Technology Officer and John Cogan, Chief Operating Officer
Why an AI Enhanced Approach to Pharmacovigilance Case Processing is now Non-negotiable Qinecsa CEO, Adam Sherlock has been featured in Simedics (The Journal of mHealth)
04 April 2022, London – Qinecsa Solutions announced the acquisition of MyMeds&Me Limited (MMM). Qinecsa, a leading provider of pharmacovigilance services and technologies to the
21th March 2024 —Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announce its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology,
15 December 2022, London – Qinecsa Solutions UK Ltd. (Qinecsa) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth). Qinecsa, a leading provider of pharmacovigilance
